Tech Company Financing Transactions
ChemLex Funding Round
On 12/7/2025, ChemLex secured $45 million in investment from Granite Asia and private investors.
Transaction Overview
Company Name
Announced On
12/7/2025
Transaction Type
Venture Equity
Amount
$45,000,000
Round
Undisclosed
Investors
Granite Asia (Lead Investor) (Yinghui Kuang)
Proceeds Purpose
The new funding will support the hiring of more hardware and software engineers, as well as chemists in Singapore, enabling the company to serve a broader pipeline of pharmaceutical and materials science projects.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Singapore, Undisclosed
Singapore
Singapore, Undisclosed
Singapore
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
ChemLex is a Singapore-based company delivering autonomous chemical synthesis services for the pharmaceutical and biotech industry. Our AI-integrated autonomous synthesis platform improves quality, consistency, and productivity while reducing costs and supporting ESG goals.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sean Lin
Browse more venture capital transactions:
Prev: 12/5/2025: Iceye venture capital transaction
Next: 12/8/2025: Resemble AI venture capital transaction
Share this article
Where The Data Comes From
We document every notable VC transaction. All VC database entries reported here come from publicly available VC deal announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs